Definition:Non-binding offer letter
✉️ Non-binding offer letter is the formal written document through which a prospective buyer communicates a non-binding offer to the seller or the seller's advisors during an insurance M&A process. While closely related to the NBO itself — and sometimes used interchangeably — the letter is the physical or electronic instrument that memorializes the indicative terms, distinguishing it from verbal expressions of interest. In insurance transactions, the letter is crafted with particular care because it simultaneously signals commercial seriousness and preserves the buyer's flexibility to adjust terms once detailed due diligence into reserves, capital adequacy, and portfolio quality has been completed.
📄 A well-drafted non-binding offer letter in the insurance context typically includes several core elements: the indicative price or valuation range with the methodology stated (such as a multiple of embedded value or tangible book value), the proposed deal structure (whether a share acquisition, portfolio transfer, or asset deal), key assumptions underpinning the valuation — including views on reserve adequacy and combined ratio trajectory — an outline of anticipated regulatory approvals, expected timeline to closing, and confirmation of funding sources. The letter explicitly states that its terms are non-binding and that no obligation to transact arises until definitive agreements are executed. Certain provisions, however, may be carved out as binding — most commonly confidentiality undertakings and, in some cases, a no-shop or exclusivity commitment if the seller agrees to grant one at this early stage.
🎯 The strategic importance of the non-binding offer letter extends beyond its legal content. In competitive auction processes for insurance targets, the quality, specificity, and credibility of the letter often determine which bidders progress to subsequent rounds. Sell-side advisors evaluate not only the headline price but also the realism of the buyer's assumptions about underwriting profitability, the feasibility of the proposed regulatory pathway, and the likelihood that the bidder can close without material re-trading. A vague or heavily conditioned letter may signal execution risk, while one that reflects genuine understanding of the target's insurance-specific dynamics — claims development patterns, reinsurance program structure, distribution relationships — positions the buyer as a front-runner.
Related concepts: